Piramal Enterprises Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1947

Chairman: Ajay G Piramal

Managing Director: --

Group: Piramal Ajay

Listing: NSE: PEL, BSE: 500302

Headquarters: Mumbai, Maharashtra

Website: www.piramal.com

Key Facts

Market cap: R 20,579.24 Cr

Revenue (TTM): R 14,595.15 Cr

Earnings (TTM): R 1,771.54 Cr

Cash: R 3,365.16 Cr

Total Debt: R 56,023.26 Cr

Promoters' ownership: 46.06%

Liquidity: High

52 Week range: R 606.85 - 2,666.04

Face value: R2.00

Shares outstanding: 22,55,38,290

Stock Performance

Trailing
Annual

Time Period	Piramal Enterprises	S&P BSE Healthcare*	S&P BSE Mid Cap*
YTD	-40.13	-10.87	-30.92
1 month	-36.97	-11.21	-29.18
3 months	-40.15	-11.10	-31.06
1 Year	-64.13	-17.19	-33.55
3 Years	-21.39	-7.87	-9.80
5 Years	1.36	-7.50	-0.77
10 Years	8.30	8.39	4.18

As on 03-Apr-2020 *As on 01-Apr-2020

Year	Piramal Enterprises	S&P BSE Mid Cap	S&P BSE Healthcare
2019	-34.84	-3.05	-3.55
2018	-16.36	-13.31	-5.89
2017	76.46	48.13	0.49
2016	60.88	7.97	-12.88
2015	20.60	7.43	15.06
2014	51.57	54.69	47.43
2013	5.86	-5.73	22.55

Annual Report (FY18)

Review & Analysis

Taxation boost
Research Desk . 09-Oct-2018
Big shifts
Research Desk . 04-Jul-2018
The quest for value
Mohammed Ekramul Haque . 20-Oct-2015
Companies operating with wide margins
Mohammed Ekramul Haque . 08-Oct-2015
Rate Cuts are No Panacea
Vikas Vardhan . 16-Feb-2015

News & Announcements